Clinical trial
Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone…
NCT00152867 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00152867 |
|---|---|
| Title | Dexamethasone Study: Impact on Quality of Life of Continuing Dexamethasone Following Emetogenic Chemotherapy |
| Official title | A Randomised Double-Blind Placebo Controlled Cross Over Trial of the Impact on Quality of Life of Continuing Dexamethasone Beyond 24 Hours Following Moderately Emetogenic Chemotherapy |
| Lead sponsor | University Health Network, Toronto, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cancer, Emesis, Nausea |
| Intervention type | Drug |
| Interventions | Dexamethasone |
| Enrollment | 86 |
| Start date | Jan 1, 2005 |
| Primary completion | Sep 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | Sep 9, 2005 |
| Last update posted | Jun 28, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: